Literature DB >> 638162

The importance of the lysophosphatidylcholine and choline moiety of bile phosphatidylcholine in lymphatic transport of fat.

P Tso, J Lam, W J Simmonds.   

Abstract

A luminal supply of biliary phosphatidylcholine is important in the translocation of absorbed fat into lymph and in the amount and composition of phosphatidylcholine concurrently synthesized. This study was undertaken to determine whether the effect was due to absorbed lysophosphatidylcholine, to a specific (1-palmitoyl) biliary lysophosphatidylcholine or to extra choline supplied by lysophosphatidylcholine. Rats with bile fistulae and thoracic duct lymph fistulae were given test meals of oleic acid and monoolein (molar ratio 2 : 1) infused duodenally for 8 h. Addition of choline chloride to the test meal increased lymphatic output of triglyceride and phospholipid but not to values found previously in rats with supplements of bile phosphatidylcholine or with bile ducts intact. Addition of dioleoyl phosphatidylcholine increased triglyceride and phospholipid output to values found in rats with intact bile ducts. Since dioleoyl phosphatidylcholine was as efficient as biliary phosphatidylcholine it was concluded that a luminal supply of 1-palmitoyl lysophosphatidylcholine was not essential. It seemed likely from the smaller effect of supplemented choline and from the fatty acid composition of lymph phosphatidylcholine that the essential requirement was a supply of absorbed lysophosphatidylcholine for rapid reacylation to phosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638162     DOI: 10.1016/0005-2760(78)90025-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Bile increases intestinal lymphatic drug transport in the fasted rat.

Authors:  Natalie L Trevaskis; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

2.  Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis.

Authors:  S Parthasarathy; D Kritchevsky; W J Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine.

Authors:  H Wang; J Du; S Lu; Y Yao; F Hunter; D D Black
Journal:  Lipids       Date:  2001-07       Impact factor: 1.880

4.  Dietary long-chain PUFA in the form of TAG or phospholipids influence lymph lipoprotein size and composition in piglets.

Authors:  Laura Amate; Angel Gil; María Ramírez
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

5.  Phospholipids affect the intestinal absorption of carotenoids in mice.

Authors:  Vallikannan Baskaran; Tatsuya Sugawara; Akihiko Nagao
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

6.  Lysophosphatidylcholine increases the secretion of cholesteryl ester-poor triacylglycerol-rich lipoproteins by CaCo-2 cells.

Authors:  F J Field; E Born; H Chen; S Murthy; S N Mathur
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

7.  Utilization of individual lecithins in intestinal lipoprotein formation in the rat.

Authors:  G M Patton; S B Clark; J M Fasulo; S J Robins
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  The importance of the steric configuration of lysophosphatidylcholine in the lymphatic transport of fat.

Authors:  P J O'Doherty
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

9.  Intestinal cholesterol uptake from phospholipid vesicles and from simple and mixed micelles.

Authors:  A B Thomson; L Cleland
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880

10.  Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in caco-2 cells.

Authors:  Takanari Nakano; Ikuo Inoue; Shigehiro Katayama; Makoto Seo; Seiichiro Takahashi; Shigeru Hokari; Rina Shinozaki; Kazuhisa Hatayama; Tsugikazu Komoda
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.